Clinical Laboratory News

Featured Clinical Laboratory News

COLA completes ISO re-certification

COLA, the only laboratory accreditation provider that operates its accreditation program in accordance with a quality management system certified to ISO 9001, recently passed its audit. The audit from the British Standards Institute (BSI) extended its ISO certification to COLA’s newly launched FDA Third Party Review Services. COLA’s ISO 9001 certificate covers the delivery and…

Details

CMS approves COLA for virtual laboratory surveys

COLA continues to expand its capabilities to support laboratories during COVID-19, and recently the Centers for Medicare and Medicaid Services (CMS) has approved COLA’s virtual survey process. This process was submitted in response to the current pandemic and its effect on the ability to perform surveys within the timeframe required by CMS. “Currently, we anticipate…

Details

COLA Publishes 2020 Laboratory Accreditation Manual with New and Revised Criteria for Accreditation Customers

On May 18, 2020, COLA published the latest version of their Laboratory Accreditation Manual.  COLA laboratories and COLA surveyors apply the criteria in the Laboratory Accreditation Manual to assess compliance.   COLA accredits laboratories that are in compliance with the COLA criteria and these laboratories are recognized by the Centers for Medicare and Medicaid Services (CMS)…

Details

Recent Articles

ZIKA Virus and ZIKA Virus Infection

Instant Access Webinar Presented by John Daly, Chief Medical Officer, COLA Description: Over the past year, Zika virus and virus infection have been in the news on a regular basis. This presentation gives a very brief overview of Zika and provides information on clinical and laboratory resources that are kept updated and can be utilized…

Credit: Architect of the Capitol

What Does the Debt Ceiling Deal Mean for Labs?

The American Clinical Laboratory Association, of which COLA is an associate member, prepared this analysis of the impact the debt ceiling compromise agreed to by President Obama and Congress will have on the lab industry. The Debt Ceiling Compromise and What It Means for Labs The legislation, once enacted, sets up essentially two stages to…

The Impact of the PAMA Regulations on POLs – PART 2

Instant Access Webinar Hosted by John Daly, M.D., Chief Medical Officer, COLA Description: Dr. Daly presents a comprehensive background of the Protecting Access to Medicare Act (PAMA.) CMS has recently released the HCPCS codes that must be reported under the PAMA regulations. This brief update discusses reportable analytes and location of the applicable test codes.…

The Impact of PAMA Regulations on POLS – Part 4

Instant Access Webinar Hosted by John Daly, M.D., Chief Medical Officer, COLA Description: Dr. Daly presents a comprehensive background of the Protecting Access to Medicare Act (PAMA.) This update covers the CMS update of the Frequent Asked Questions about the PAMA regulations. The update aims to provide further clarification as to which physician office-based labs will be…

The Impact of PAMA Regulations on POLS – Part 3

Instant Access Webinar Hosted by John Daly, M.D., Chief Medical Officer, COLA Description: Dr. Daly presents a comprehensive background of the Protecting Access to Medicare Act (PAMA.) This PAMA update informs of the CMS newly released laboratory test reporting format. Learn More from CMS by Clicking Here Cost: FREE Click Here to View The Impact of…

The Impact of PAMA Regulations on POLs

In 2014, Congress passed PAMA Regulations (Protecting Access to Medicare Act) to direct the Centers for Medicare and Medicaid Services (CMS) to develop a market-based methodology for determining the future rates Medicare will pay for tests under the Clinical Laboratory Fee Schedule. Analysis shows that the current data collection and evaluative pricing methodology, if fully…